The UAE has become the second country to approve once-daily, oral pill - Lipfendra - to treat adults with elevated low-density lipoprotein (LDL-C) cholesterol, a leading risk factor for cardiovascular disease.
Making the announcement, the Emirates Drug Establishment (EDE) explained that Lipfendra can also treat "certain inherited conditions" as long as it is cleared by a healthcare professional.
It is said to expand treatment options for adults and improve their quality of life.
Patients are advised to maintain a balanced diet and regular physical activity alongside the treatment.
The move is part of efforts by the UAE to authorise innovative medicines and expand treatment options for adults.
UAE sends humanitarian aid to earthquake-hit Colombia
UAE calls for global action to combat extremism and hate speech
Four UAE aid convoys deliver 781 tonnes of supplies to Gaza
Etihad Rail launches cargo service from Fujairah to Industrial City of Abu Dhabi
H.H. Sheikh Hamdan announces new Acting Director General of Dubai Ruler's Court
